Dysarthria Clinical Trials

Find Dysarthria Clinical Trials Near You

Evaluating Dysarthria Through Acoustic and Respiratory Parameters: A Clinical Protocol

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to describe speech and breathing patterns in adults after acquired brain injury (ABI) and understand how these patterns relate to the presence, severity, and type of dysarthria. The main questions it aims to answer are: * What changes in voice and breathing are observed in adults with dysarthria after ABI? * Can combining acoustic, respiratory, and clinical assessments help identify dysarthria severity and subtype? Participants will: * Have their speech recorded to measure voice and articulation features, such as pitch, clarity, and the ability to sustain sounds. * Perform breathing tests using a spirometer to assess lung function. * Complete the Frenchay Dysarthria Assessment-2 (FDA-2), adapted to Spanish, to classify dysarthria type and severity. About 97 to 101 participants will take part. The results will help speech therapists better detect, evaluate, and treat dysarthria in adults after brain injury.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults aged 18 years or older at the time of enrollment.

⁃ Diagnosed with acquired brain injury (ABI), including:

• Stroke

• Traumatic brain injury (TBI)

• Brain tumor

• Ability to provide written informed consent (or via a legally authorized representative if necessary).

• Cognitive function preserved, defined as a Mini-Mental State Examination (MMSE) score ≥ 24.

Locations
Other Locations
Spain
University of Salamanca
RECRUITING
Salamanca
Contact Information
Primary
AHMED ARGOUBI, Speech Language Pathologist
ahmedargoubi@usal.es
+34 652555591
Backup
Ana-María Martín-Nogueras, Investigator/ Profesor
anamar@usal.es
+34 669284767
Time Frame
Start Date: 2025-10-15
Estimated Completion Date: 2026-10-15
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: University of Salamanca

This content was sourced from clinicaltrials.gov